Robert C. Green
Robert C. Green is a medical geneticist who directs the G2P Research Program (genomes2people.org) in translational genomics and health outcomes at Brigham and Women’s Hospital and Harvard Medical School. He has been continuously funded by NIH for over 26 years and has published over 300 scientific articles. Green led the first experimental trials disclosing common complex disease risk (the REVEAL Study), one of the first prospective studies of direct-to-consumer genetic testing services (the PGen Study) and was lead author on recent ACMG recommendations for return of secondary findings in clinical sequencing. He currently leads and co-leads the MedSeq Project and the BabySeq Project, respectively, two NIH-funded randomized trials designed to explore the medical, behavioral and economic implications of integrating genome sequencing into the medical care of adults and newborns.